Patient Square Capital LP Portfolio Holdings

Patient Square Capital LP

  • $242 Billion
  • Q1 2025

Patient Square Capital LP has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $242 Billion distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $126B, Insmed Inc with a value of $25.2B, Liquidia Corp with a value of $22.5B, Eye Point Pharmaceuticals, Inc. with a value of $8.03B, and Ocular Therapeutix, Inc with a value of $6.75B.

Examining the 13F form we can see an decrease of $25.7B in the current position value, from $267B to 242B.

Patient Square Capital LP is based out at Menlo Park, CA

Below you can find more details about Patient Square Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $242 Billion
Healthcare: $231 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$8.13B
$126 Billion 52.09% of portfolio
12,480,000
Q4 2024 Added 2.06%
$14.3B
$25.2 Billion 10.42% of portfolio
330,250
Q1 2025 Added 7.51%
$863M
$22.5 Billion 9.29% of portfolio
1,522,452
Q1 2025 Reduced 18.16%
$304M
$8.03 Billion 3.32% of portfolio
1,481,977
Q1 2025 Added 5.08%
$710M
$6.75 Billion 2.79% of portfolio
920,199
Q1 2025 Added 95.4%
$358M
$6.65 Billion 2.75% of portfolio
878,897
Q4 2024 Added 6.57%
$564M
$5.31 Billion 2.2% of portfolio
447,296
Q1 2025 Added 0.22%
$1.88B
$5.24 Billion 2.17% of portfolio
116,362
Q1 2025 Added 79.29%
Enliven Therapeutics, Inc.
-
$5 Billion 2.07% of portfolio
-
Q1 2025 Added 13.3%
$1.74B
$4.95 Billion 2.05% of portfolio
154,000
Q1 2025 Added 381.25%
Disc Medicine, Inc.
-
$4.12 Billion 1.7% of portfolio
-
Q1 2025 Added 47.16%
$1.83B
$4.09 Billion 1.69% of portfolio
139,732
Q1 2025 Added 14.79%
$2.58B
$3.89 Billion 1.61% of portfolio
142,201
Q1 2025 New
$581M
$3.85 Billion 1.59% of portfolio
245,496
Q1 2025 Added 18.25%
$180M
$3.46 Billion 1.43% of portfolio
2,368,186
Q1 2025 Added 58.95%
$7.66B
$3.41 Billion 1.41% of portfolio
38,500
Q1 2025 New
Soleno Therapeutics, Inc.
-
$1.33 Billion 0.55% of portfolio
-
Q1 2025 New
Vyne Therapeutics Inc.
-
$406 Million 0.17% of portfolio
-
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 19
  • Current Value $242 Billion
  • Prior Value $267 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 4 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Patient Square Capital LP Portfolio

Follow Patient Square Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Square Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Patient Square Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email